Filing Details

Accession Number:
0001209191-21-025370
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-05 18:17:23
Reporting Period:
2021-04-01
Accepted Time:
2021-04-05 18:17:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc. FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400973 F John Crowley C/O Amicus Therapeutics, Inc.
3675 Market Street
Philadelphia PA 19104
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-01 7,500 $10.00 821,524 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 64,895 Indirect By Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.